Scheelevägen 22
Lund 223 63
Sweden
https://ziccum.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 10
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Ms. Ann Gidner | MD & CEO | 3.72M | N/A | 1966 |
Mr. Xavier Turon | Chief Operating Officer | N/A | N/A | 1975 |
Mr. Fabrice Rose | Scientific Director | N/A | N/A | 1975 |
Ziccum AB (publ) develops dry powder preparations of biological pharmaceuticals. It develops and commercializes LaminarPace, a spray drying technology that dries liquid biopharmaceuticals, such as vaccines or protein therapeutics into a particle engineered powder product. The company was incorporated in 2017 and is headquartered in Lund, Sweden.
Ziccum AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.